134 related articles for article (PubMed ID: 202665)
1. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
[TBL] [Abstract][Full Text] [Related]
2. Early and late components of Epstein-Barr virus-associated membrane antigen in superinfected Daudi cells and their reactivity with sera from nasopharyngeal carcinoma patients.
Hinuma Y; Sairenji T; Maeda M
IARC Sci Publ (1971); 1978; (20):385-90. PubMed ID: 215521
[TBL] [Abstract][Full Text] [Related]
3. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Coker-Vann M; Dolin R
J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet inactivation of Epstein-Barr virus: effect on synthesis of virus-associated antigens.
Sairenji T; Hinuma Y
Int J Cancer; 1975 Jul; 16(1):1-6. PubMed ID: 170209
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
Patel PC; Menezes J
Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.
Dölken G; Klein G
Virology; 1976 Mar; 70(1):210-3. PubMed ID: 176804
[No Abstract] [Full Text] [Related]
7. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
Lidin BI; Lamon EW
Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
9. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
Takaki K; Harada M; Sairenji T; Hinuma Y
J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
[TBL] [Abstract][Full Text] [Related]
10. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
[TBL] [Abstract][Full Text] [Related]
11. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
Fujiwara S; Takada K; Yano S; Osato T
Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
[TBL] [Abstract][Full Text] [Related]
12. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
13. Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.
Sculley TB; Sculley DG; Pope JH
J Gen Virol; 1985 May; 66 ( Pt 5)():1113-22. PubMed ID: 2582083
[TBL] [Abstract][Full Text] [Related]
14. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
Casareale D; Jones W; Sairenji T; Humphreys RE
Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
[TBL] [Abstract][Full Text] [Related]
15. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
Tovey MG; Dron M; Gresser I
J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
Mueller-Lantzsch N; Yamamoto N
J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of 1-beta-D-arabinofuranosylthymine on synthesis of Epstein-Barr virus.
Yonemura K; Sairenji T; Hinuma Y
Microbiol Immunol; 1981; 25(6):557-63. PubMed ID: 6268944
[TBL] [Abstract][Full Text] [Related]
18. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
Klein G; Zeuthen J; Ber R; Ernberg I
J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
Takada K; Fujiwara S; Yano S; Osato T
Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
[TBL] [Abstract][Full Text] [Related]
20. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]